Regulatory T cells in cancer immunotherapy

Tanaka, Atsushi, Sakaguchi, Shimon·2017·Cell Research

DOI 10.1038/cr.2016.151

Cited by (1,001)

Items 201–300 of 1,001

IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development
Amy Li, Rebecca H. Herbst, David A. Canner, Jason M. Schenkel, Olivia C. Ghirardelli Smith, Jonathan Y. Kim, Michelle Hillman, Arjun J. Bhutkar, Michael S. Cuoco, C. Garrett Rappazzo et al. · 2019 · Cell Reports
Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies
Stefan Kiesgen, Leonardo Chicaybam, Navin K. Chintala, Prasad S. Adusumilli · 2017 · Journal of Thoracic Oncology
FOXOs in cancer immunity: Knowns and unknowns
Youcai Deng, Fangjie Wang, Tiffany L. Hughes, Jianhua Yu · 2018 · Seminars in Cancer Biology
Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses
Fabien Pitoiset, Lydie Cassard, Karim El Soufi, Lisa Boselli, Jonathan Grivel, Alexandra Roux, David Klatzmann, Nathalie Chaput, Michèlle Rosenzwajg · 2018 · Cytometry Part A
Tumor immune response and immunotherapy in gastric cancer
Yoonjin Kwak, An Na Seo, Hee Eun Lee, Hye Seung Lee · 2019 · Journal of Pathology and Translational Medicine
Influence of Estrogen on the NSCLC Microenvironment: A Comprehensive Picture and Clinical Implications
Tanner Smida, Tullia Carmela Bruno, Laura P. Stabile · 2020 · Frontiers in Oncology
Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications
Yi Wei Dong, Cuiping Yang, Fan Pan · 2021 · Frontiers in Immunology
The progress of immune checkpoint therapy in primary liver cancer
Yi-Min Zheng, Siwei Wang, Jiabin Cai, Ai‐Wu Ke, Jia Fan · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma
Tomonari Kinoshita, Chie Kudo‐Saito, Reiko Muramatsu, Tomonobu Fujita, Miyuki Saito, Haruna Nagumo, Toshiharu Sakurai, Shinobu Noji, Emi Takahata, Tomonori Yaguchi et al. · 2017 · European Journal of Cancer
T‐cell modulation by cyclophosphamide for tumour therapy
Ellyn Hughes, Martin J. Scurr, Emma Campbell, Emma Jones, Andrew J Godkin, Awen Gallimore · 2018 · Immunology
α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
Yingting Zhang, Ryan Springfield, Siyang Chen, Xin Li, Xiaotian Feng, Rosa Moshirian, Rirong Yang, Weiming Yuan · 2019 · Frontiers in Immunology
Applications of Raman spectroscopy in the development of cell therapies: state of the art and future perspectives
Shreyas Rangan, Hans Georg Schulze, Martha Z. Vardaki, Michael W. Blades, James M. Piret, Robin F. B. Turner · 2020 · The Analyst
Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance
Michele Zanoni, Sara Bravaccini, Francesco� Fabbri, Chiara Arienti · 2022 · Frontiers in Medicine
Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy
Mandy van Gulijk, Floris F. Dammeijer, Joachim G.J.V. Aerts, Heleen H. Vroman · 2018 · Frontiers in Immunology
Adenosine in cancer immunotherapy: Taking off on a new plane
Chenyue Zhang, Kai Wang, Haiyong Wang · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
The role of regulatory T cells in the pathogenesis and treatment of prostate cancer
Vahid Karpisheh, Seyedeh Mahboubeh Mousavi, Parinaz Naghavi Sheykholeslami, Mehrdad Fathi, Mehran Mohammadpour Saray, Leili Aghebati Maleki, Reza Jafari, Naime Majidi Zolbanin, Farhad Jadidi‐Niaragh · 2021 · Life Sciences
COL1A1 is a prognostic biomarker and correlated with immune infiltrates in lung cancer
Qishun Geng, Zhibo Shen, Lifeng Li, Jie Zhao · 2021 · PeerJ
Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling
Pei‐Yu Chen, Wen-Fei Wei, Hong-Zhen Wu, Liangsheng Fan, Wei Wang · 2021 · Frontiers in Immunology
Immune response drives outcomes in prostate cancer: implications for immunotherapy
Jialin Meng, Yujie Zhou, Xiaofan Lu, Zichen Bian, Yiding Chen, Song Fan, Jun Zhou, Li Zhang, 郝宗耀, Meng Zhang et al. · 2020 · Molecular Oncology
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy
Wenquan Ou, Samantha Stewart, Alisa M. White, Elyahb Allie Kwizera, Jiangsheng Xu, Yuanzhang Fang, James G. Shamul, Changqing Xie, Suliat M. Nurudeen, Nikki P. Tirada et al. · 2023 · Nature Communications
Phase I/II clinical trial of a Wilms’ tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer
Wen Zhang, Lu Xu, Peilin Cui, Chunmei Piao, Man Xiao, Xuesong Liu, Yue Wang, Xuan Wu, Jingwei Liu, Lin Yang · 2018 · Cancer Immunology Immunotherapy
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer
Erika Jensen‐Jarolim, Heather J. Bax, Rodolfo Bianchini, Silvia Crescioli, Tracy R. Daniels‐Wells, David Dombrowicz, Edda Fiebiger, Hannah Jane Gould, Sheeba Irshad, Jozef Janda et al. · 2017 · Allergy
Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity
Kazuhiko Matsuo, Osamu Yoshie, Takashi Nakayama · 2021 · Cancers
AMPK–a key factor in crosstalk between tumor cell energy metabolism and immune microenvironment?
Na Wang, Bofang Wang, Ewetse Paul Maswikiti, Yang Yu, Kewei Song, Chenhui Ma, Xiaowen Han, Huanhuan Ma, Xiaobo Deng, Rong Yu et al. · 2024 · Cell Death Discovery
The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine
Xiaojun Su, Xiuli Yan, Hui Zhang · 2025 · Molecular Cancer
Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?
Vahidian, Fatemeh, Duijf, Pascal H.G., Safarzadeh, Elham, Derakhshani, Afshin, Baghbanzadeh, Amir, Baradaran, Behzad · 2019 · Immunology Letters
The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies
José Manuel González-Navajas, Dengxia Denise Fan, Shuang Yang, Fengyuan Mandy Yang, Beatriz Lozano‐Ruiz, Liya Shen, Jong‐Dae Lee · 2021 · Frontiers in Immunology
Targeting of the tumor microenvironment by curcumin
Xiao Fu, Yingni He, Mu Li, Zezhi Huang, Masoud Najafi · 2021 · BioFactors
Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
Chaoyuan Kuang, Yongseok Park, Ryan C. Augustin, Yan Lin, Douglas J. Hartman, Lindsey Seigh, Reetesh K. Pai, Weijing Sun, Nathan Bahary, James P. Ohr et al. · 2022 · Clinical Epigenetics
Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer
Yu-Chang Wang, Rui Chen, Yue Wa, Shikuan Ding, Yijian Yang, Junbo Liao, Lei Tong, Gelei Xiao · 2022 · Frontiers in Immunology
Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression
Yu Wang, Jiazhou Li, Shingo Nakahata, Hidekatsu Iha · 2024 · International Journal of Molecular Sciences
Exosomes derived from B16F0 melanoma cells alter the transcriptome of cytotoxic T cells that impacts mitochondrial respiration
Cassidy L. Bland, Christina Nicole Nikki Byrne-Hoffman, Audry Fernández, Stephanie L. Rellick, Wentao Deng, David J. Klinke · 2018 · FEBS Journal
Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer
Yingjie Nie, Jiang He, Hidekazu Shirota, Anna L. Trivett, De Yang, Dennis M. Klinman, Joost J. Oppenheim, Xin Chen · 2018 · Science Signaling
Roles of the RANKL–RANK Axis in Immunity—Implications for Pathogenesis and Treatment of Bone Metastasis
Bo Li, Pengru Wang, Jian Jiao, Haifeng Wei, Wei Xu, Pingting Zhou · 2022 · Frontiers in Immunology
Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy
Francesco Perri, Franco Ionna, Francesco Longo, Giuseppina Della Vittoria Scarpati, Carmine De Angelis, Alessandro Ottaiano, Gerardo Botti, Francesco Caponigro · 2019 · Translational Oncology
HDAC10 deletion promotes Foxp3+ T-regulatory cell function
Satinder Dahiya, Ulf Henning Beier, Liqing Wang, Rongxiang Han, Jing Jiao, Tatiana Akimova, Alessia Angelin, Douglas C. Wallace, Wayne W. Hancock · 2020 · Scientific Reports
Shikonin and chitosan-silver nanoparticles synergize against triple-negative breast cancer through RIPK3-triggered necroptotic immunogenic cell death
Jiahao Liang, Xiangge Tian, Meirong Zhou, Fei Yan, Jialong Fan, Yan Qin, Binlong Chen, Xiaokui Huo, Zhenlong Yu, Yan Tian et al. · 2024 · Biomaterials
Pharmacokinetic and Immunological Considerations for Expanding the Therapeutic Window of Next-Generation Antibody–Drug Conjugates
Eshita Khera, Greg M. Thurber · 2018 · BioDrugs
Depleting Tumor-Associated Tregs Via Nanoparticle-Mediated Hyperthermia to Enhance Anti-CTLA-4 Immunotherapy
Hongwei Chen, Xin Luan, Hayley J. Paholak, Joseph Burnett, Nicholas O. Stevers, Kanokwan Sansanaphongpricha, Miao He, Alfred E. Chang, Qiao Li, Duxin Sun · 2019 · Nanomedicine
BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppression
Francis M. Grant, Jie Yang, Rabab Nasrallah, James D. Clarke, Firas Sadiyah, Sarah K. Whiteside, Charlotte J. Imianowski, Paula Kuo, Panagiota Vardaka, Tihomir Zh Todorov et al. · 2020 · The Journal of Experimental Medicine
Clonally expanded EOMES+ Tr1-like cells in primary and metastatic tumors are associated with disease progression
Raoul J.P. Bonnal, Grazisa Rossetti, Enrico Lugli, Marco Claudio De Simone, Paola Gruarin, Jolanda Brummelman, Lorenzo Drufuca, Marco Passaro, Ramona Bason, Federica Gervasoni et al. · 2021 · Nature Immunology
Scientific rationale for combination immunotherapy of hepatocellular carcinoma with anti–PD-1/PD-L1 and anti–CTLA-4 antibodies
Kudo, Masatoshi · 2019 · Liver Cancer
Biotin Deficiency Induces Th1- and Th17-Mediated Proinflammatory Responses in Human CD4+ T Lymphocytes via Activation of the mTOR Signaling Pathway
Asif Elahi, Subrata Sabui, Nell Narasappa, Sudhanshu Agrawal, Nils W. G. Lambrecht, Anshu Agrawal, Hamid M. Said · 2018 · The Journal of Immunology
Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy
Tuan Hiep Tran, Thi Thu Phuong Tran, Duy Hieu Truong, Hanh Thuy Nguyen, Tung Thanh Pham, Chul Soon Yong, Jong Oh Kim · 2019 · Acta Biomaterialia
The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy
Rikito Endo, Takashi Nakamura, Kyoko Kawakami, Yusuke Sato, Hideyoshi Harashima · 2019 · Scientific Reports
Elevated levels of IL‑17A and IL‑35 in plasma and bronchoalveolar lavage fluid are associated with checkpoint inhibitor pneumonitis in patients with non‑small cell lung cancer
Yi Wang, Dan Wen Lou, Dan Li, Wei Jiang, Jing Dong, Wei Gao, Hong Chen · 2020 · Oncology Letters
Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?
Muhammad Sadeqi Nezhad, Alexander Marcus Seifalian, Nader Bagheri, Sajad Yaghoubi, Mohammad Hossein Karimi, Meghdad Adbollahpour-Alitappeh · 2020 · Frontiers in Immunology
The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy
Minsu Kwon, Hanul Jung, Gi‐Hoon Nam, In-San Kim · 2021 · Journal of Controlled Release
Cancer-associated fibroblasts in cancer drug resistance and cancer progression: a review
H. Masuda · 2025 · Cell Death Discovery
Multilevel Mechanisms of Cancer Drug Resistance
Małgorzata Roszkowska · 2024 · International Journal of Molecular Sciences
Role of tryptophan metabolism in cancers and therapeutic implications
Xiaohan Liu, Xiao‐Yue Zhai · 2021 · Biochimie
Aberrant R-loop–mediated immune evasion, cellular communication, and metabolic reprogramming affect cancer progression: a single-cell analysis
Shichao Zhang, Yang Liu, Yichi Sun, Qin Liu, Yan Jennifer Gu, Ya Huang, Zhu Zeng, Fuzhou Tang, Yan Ouyang · 2024 · Molecular Cancer
Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment
Robert A. Belderbos, Joachim G.J.V. Aerts, Heleen H. Vroman · 2019 · Molecular Therapy — Oncolytics
Probiotic species in the modulation of the anticancer immune response
Marinelli, Luciana, Tenore, Gian Carlo, Novellino, Ettore · 2017 · Seminars in Cancer Biology
CCL20 Signaling in the Tumor Microenvironment
Weilong Chen, Yuanyuan Qin, Suling Liu · 2020 · Advances in experimental medicine and biology
Cancer-Associated Fibroblasts and T Cells: From Mechanisms to Outcomes
Alfie T. Baker, Mohammed H. Abuwarwar, Lylarath Poly, Simon Wilkins, Anne L. Fletcher · 2021 · The Journal of Immunology
T Cell Exhaustion and CAR‐T Immunotherapy in Hematological Malignancies
Lu Tang, Yinqiang Zhang, Yu Hu, Heng Mei · 2021 · BioMed Research International
Single-Cell Analysis of the Pan-Cancer Immune Microenvironment and scTIME Portal
Fang Hong, Qianqian Meng, Weiyu Zhang, Ruiqin Zheng, Xiaoyun Li, Tao Cheng, Deqing Hu, Xin Gao · 2021 · Cancer Immunology Research
Harnessing immune response using reactive oxygen Species-Generating/Eliminating inorganic biomaterials for disease treatment
Caiyan Zhao, Hongzhang Deng, Xiaoyuan Shawn Chen · 2022 · Advanced Drug Delivery Reviews
Single‐cell atlas reveals a distinct immune profile fostered by T cell‐B cell crosstalk in triple negative breast cancer
Shuning Ding, Niu Qiao, Qingchen Zhu, Yiwei Tong, Shengyue Wang, Xiaosong Chen, Qiang Tian, Yichuan Xiao, Kunwei Shen · 2023 · 癌症：英文版
Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy
Dayana B. Rivadeneira, Greg M. Delgoffe · 2018 · Clinical Cancer Research
Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma
Takayuki Nakayama, Kazutaka Saito, Jiro Kumagai, Yutaka Nakajima, Toshiki Kijima, Soichiro Yoshida, Kazunori Kihara, Yasuhisa Fujii · 2018 · Clinical Genitourinary Cancer
Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular Carcinoma
Ahmed Omar Kaseb, Luis M. Vence, Jorge M. Blando, Shalini Singh Yadav, Naruhiko Ikoma, Roberto Carmagnani Pestana, Jean‐Nicolas Vauthey, James Patrick Allison, Padmanee Sharma · 2019 · Cancer Immunology Research
Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy
Paulina Czajka‐Francuz, Maria J. Prendes, Arun K. Mankan, Ángela Quintana, Sarabjot Pabla, Shakti H Ramkissoon, Taylor J. Jensen, Sandra Peiró, Eric Allan Severson, Bhagelu R. Achyut et al. · 2023 · Frontiers in Oncology
OX40/OX40 ligand and its role in precision immune oncology
Bicky Thapa, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary Nesline, Rebecca A. Previs, Jeff Conroy, Paul DePietro, Sarabjot Pabla et al. · 2024 · Cancer and Metastasis Reviews
Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics
Chenbo Ding, Wendong Tang, Xiaobo Fan, Guoqiu Wu · 2018 · OncoTargets and Therapy
Aldehyde dehydrogenase in regulatory T‐cell development, immunity and cancer
Christopher G. Bazewicz, Saketh Sriram Dinavahi, Todd D. Schell, Gavin P. Robertson · 2018 · Immunology
An oral bait vaccination approach for the Tasmanian devil facial tumor diseases
Andrew S. Flies, Emily J. Flies, Samantha Fox, Amy T. Gilbert, Shylo R. Johnson, Guei‐Sheung Liu, A. Bruce Lyons, Amanda L. Patchett, David Pemberton, Ruth J. Pye · 2020 · Expert Review of Vaccines
CCR7 Mediated Mimetic Dendritic Cell Vaccine Homing in Lymph Node for Head and Neck Squamous Cell Carcinoma Therapy
Jiabin Xu, Hong Liu, Tao Wang, Zhenfu Wen, Haolin Chen, Zeyu Yang, Liyan Li, Shan Yu, Siyong Gao, Le Yang et al. · 2023 · Advanced Science
IL-23 stabilizes an effector Treg cell program in the tumor microenvironment
Tobias Wertheimer, Pascale Zwicky, Lukas Rindlisbacher, Colin Sparano, Marijne Vermeer, Bruno Marcel Silva de Melo, Claudia Haftmann, Tamina Rückert, Aakriti Sethi, Stefanie Schärli et al. · 2024 · Nature Immunology
Human lung tumor FOXP3+ Tregs upregulate four “Treg-locking” transcription factors
Tatiana Akimova, Tianyi Zhang, Dmitri G. Negorev, Sunil Kumar Singhal, Jason E. Stadanlick, Abhishek Rao, Michael J. Annunziata, Matthew H. Levine, Ulf Henning Beier, Joshua Matthew Diamond et al. · 2017 · JCI Insight
The Tumor Microenvironment of Bladder Cancer
Ken Hatogai, Randy F. Sweis · 2020 · Advances in experimental medicine and biology
Current understandings and clinical translation of nanomedicines for breast cancer therapy
Yike Jiang, Ziyi Jiang, Mingzhe Wang, Lan Ma · 2021 · Advanced Drug Delivery Reviews
Differential roles of regulatory T cells in acute respiratory infections
Milica Jovisic, Nurbek Mambetsariev, Benjamin David Singer, Luisa Morales‐Nebreda · 2023 · Journal of Clinical Investigation
Genetic Epidemiology of Breast Cancer in Latin America
Valentina A. Zavala, Silvia Juliana Serrano-Gomez, Julie Dutil, Laura Fejerman · 2019 · Genes
The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy
Ryuhei Okada, Yasuhiro Maruoka, Aki Furusawa, Fuyuki F. Inagaki, Tadanobu Nagaya, Daiki Fujimura, Peter L. Choyke, Hisataka Kobayashi · 2019 · Bioconjugate Chemistry
ITCH as a potential therapeutic target in human cancers
Qing Yin, Clayton J. Wyatt, Tao Han, Keiran S.M. Smalley, Lixin Wan · 2020 · Seminars in Cancer Biology
Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy.
Jaehyun Kim, Juhyeong Hong, Jieun Lee, S. F. Lahiji, Yong-Hee Kim · 2021 · Journal of Controlled Release
The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions—Evidence for Estrogen as an Immunomodulator
Rudrapatna Subramanyam Jayshree · 2021 · Frontiers in Cellular and Infection Microbiology
Mechanisms of esophageal cancer metastasis and treatment progress
Yusheng Wang, Wei Yang, Qianyun Wang, Yong Jiang Zhou · 2023 · Frontiers in Immunology
FOXP3+ regulatory T cell perturbation mediated by the IFNγ-STAT1-IFITM3 feedback loop is essential for anti-tumor immunity
Xinnan Liu, Weiqi Zhang, Yichao Han, Hao Cheng, Qi Liu, Shouyu Ke, Fangming Zhu, Ying Chun Lu, Xin Dai, Chuan Wang et al. · 2024 · Nature Communications
Notch and NF-κB: Coach and Players of Regulatory T-Cell Response in Cancer
Francesca Ferrandino, Paola Grazioli, Diana Bellavia, Antonio Francesco Campese, Isabella Screpanti, María Pía Felli · 2018 · Frontiers in Immunology
Single-Cell Profiling Defines Transcriptomic Signatures Specific to Tumor-Reactive versus Virus-Responsive CD4+ T Cells
Assaf Magen, Jia Nie, Thomas Ciucci, Samira Tamoutounour, Yongmei Zhao, Monika Mehta, Bao Quoc Tran, Dorian B. McGavern, Sridhar S. Hannenhalli, Rémy Bosselut · 2019 · Cell Reports
CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness
Shingo Inaguma, Jerzy P. Lasota, Piotr Czapiewski, Renata Langfort, Janusz Ryś, Joanna Szpor, Piotr Waloszczyk, Krzysztof Okoń, Wojciech Biernat, David S. Schrump et al. · 2019 · The Journal of Pathology
The TNF-α/TNFR2 Pathway: Targeting a Brake to Release the Anti-tumor Immune Response
Audrey Moatti, José Laurent Cohen · 2021 · Frontiers in Cell and Developmental Biology
Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
Milad Taghizadeh-Anvar, Kimiya Rashidan, Nima Arsam, Ashkan Rasouli‐Saravani, Hamidreza Yadegari, Ali Ahmadi, Zeynab Asgari, Ahmad Ghorbani Vanan, Farid Ghorbaninezhad, Safa Tahmasebi · 2024 · Cancer Cell International
Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion
Xia Yang, Chunye Huang, Min Zhong, Hongguang Zhong, Ruiwen Ruan, Jianping Xiong, Yangyang Yao, Jing Zhou, Jun Deng · 2025 · Cell Communication and Signaling
Regulatory T cells in solid tumor immunotherapy: effect, mechanism and clinical application
Yan Pan, Hanqiong Zhou, Zhenqiang Sun, Yichen Zhu, Zhe Zhang, Jing Han, Yang Liu, Qiming Wang · 2025 · Cell Death and Disease
Modulation of regulatory T cells by natural products in cancer
Afsane Bahrami, Mohammad Fereidouni, Matteo Pirro, Vanessa Bianconi, Amirhossein Sahebkar · 2019 · Cancer Letters
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
Abhishek S. Kashyap, Tamara Thelemann, Richard Klar, Sandra M. Kallert, Julia Festag, Mélanie Buchi, Lisa Hinterwimmer, Monika Schell, Sven Michel, Frank Jaschinski et al. · 2019 · Journal for ImmunoTherapy of Cancer
The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer
Miya Haruna, Azumi Ueyama, Yoko Yamamoto, Michinari Hirata, Kumiko Goto, Hiroshi Yoshida, Naoko Higuchi, Tetsuya Yoshida, Yujiro Kidani, Yamami Nakamura et al. · 2022 · Scientific Reports
Mutations in DNA repair genes are associated with increased neo-antigen load and activated T cell infiltration in lung adenocarcinoma
Young Kwang Chae, Jonathan Forrest Anker, Preeti Bais, Sandeep Namburi, Francis Joseph Giles, Jeffrey H. Chuang · 2017 · Oncotarget
High-dimensional single-cell analysis delineates radiofrequency ablation induced immune microenvironmental remodeling in pancreatic cancer
Qinglin Fei, Yu Pan, Wenji Lin, Yuanyuan Zhou, Xingxing Yu, Zelin Hou, Xunbin Yu, Xianchao Lin, Ronggui Lin, Fengchun Lu et al. · 2020 · Cell Death and Disease
Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade
Michael L. Dixon, Lin Luo, Sadashib Ghosh, Jeffrey M Grimes, Jonathan D. Leavenworth, Jianmei Wu Leavenworth · 2021 · Molecular Cancer
Electroacupuncture Relieves Pain and Attenuates Inflammation Progression Through Inducing IL-10 Production in CFA-Induced Mice
Meiling Yu, Rui-de Wei, Tao Zhang, Jun‐Meng Wang, Yu Cheng, Fenfen Qin, Shu-Ping Fu, Zhigang Lu, Sheng-Feng Lu · 2020 · Inflammation
Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing
Meiling Cheng, Guodong Liang, Yin Zongyi, Xiaona Lin, Qihui Sun, Yang Liu · 2022 · Journal of Cancer Research and Clinical Oncology
Microenvironmental regulation of solid tumour resistance to CAR T cell therapy
Zachary L Lamplugh, Nils Wellhausen, Carl H. June, Yi Fan · 2025 · Nature reviews. Immunology
An update: emerging drugs to treat squamous cell carcinomas of the head and neck
Y. Lee, Daniel E. Johnson, J. Grandis · 2018 · Expert Opinion on Emerging Drugs
The immune system of chicken and its response to H9N2 avian influenza virus
Wenhao Yang, Xiufan Liu, Xiaoquan Wang · 2023 · Veterinary Quarterly
Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy
Prashant Sharma, Mario Otto · 2023 · Bioactive Materials